These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 10871808
1. MRI correlates of cognitive dysfunction in multiple sclerosis patients. Rovaris M, Filippi M. J Neurovirol; 2000 May; 6 Suppl 2():S172-5. PubMed ID: 10871808 [Abstract] [Full Text] [Related]
2. [Magnetic resonance imaging correlates of cognitive dysfunction in patients with multiple sclerosis]. Filippi M. Rev Neurol; 2000 May; 30(12):1253-6. PubMed ID: 10935260 [Abstract] [Full Text] [Related]
3. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. Rovaris M, Comi G, Filippi M. J Neurol Sci; 2006 Jun 15; 245(1-2):111-6. PubMed ID: 16626748 [Abstract] [Full Text] [Related]
4. Magnetisation transfer imaging in multiple sclerosis. Filippi M, Rovaris M. J Neurovirol; 2000 May 15; 6 Suppl 2():S115-20. PubMed ID: 10871798 [Abstract] [Full Text] [Related]
5. Correlations between magnetization transfer metrics and other magnetic resonance abnormalities in multiple sclerosis. Rovaris M, Horsfield MA, Filippi M. Neurology; 1999 May 15; 53(5 Suppl 3):S40-5. PubMed ID: 10496210 [Abstract] [Full Text] [Related]
6. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N. Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173 [Abstract] [Full Text] [Related]
7. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, De Stefano N. Neurology; 2008 Aug 26; 71(9):632-8. PubMed ID: 18725589 [Abstract] [Full Text] [Related]
9. Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns. Tiemann L, Penner IK, Haupts M, Schlegel U, Calabrese P. Mult Scler; 2009 Oct 26; 15(10):1164-74. PubMed ID: 19667010 [Abstract] [Full Text] [Related]
10. [Cognitive impairment]. Reuter F, Audoin B, Rico A, Malikova I, Ranjeva JP, Pelletier J. Rev Neurol (Paris); 2009 Mar 26; 165 Suppl 4():S113-22. PubMed ID: 19361675 [Abstract] [Full Text] [Related]
11. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group. Mult Scler; 2009 Jul 26; 15(7):779-88. PubMed ID: 19542262 [Abstract] [Full Text] [Related]
15. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M. Brain; 2006 Oct 26; 129(Pt 10):2620-7. PubMed ID: 16951409 [Abstract] [Full Text] [Related]
16. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis]. Zivadinov R, Sepcić J. Lijec Vjesn; 2006 Oct 26; 128(9-10):295-308. PubMed ID: 17128669 [Abstract] [Full Text] [Related]